Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapyMarie-Ève Wedge, Carolina S. Ilkow, Victoria A. Jennings et al.|Nature Communications|2022Cited by 54
Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22Scott McComb, Risini D. Weeratna, Mehdi Arbabi‐Ghahroudi et al.|Molecular Therapy Oncology|2024Cited by 12
Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlationBrian A. Keller, John C. Bell, Catia Cemeus et al.|Journal of Cancer Research and Clinical Oncology|2021Cited by 4